Understanding Cross-Country Differences in Health Status and Expenditures

Raquel Fonseca (), Francois Langot, Pierre-Carl Michaud and Thepthida Sopraseuth

CIRANO Working Papers from CIRANO

Abstract: Using a general equilibrium heterogeneous agent model featuring health production, we quantify the relative contribution of price distortions in the health market, TFP and other health risks in explaining cross-country differences in health expenditure (as a share of GDP) and health status. Estimated parameters reveal a substantial price wedge that explains at most 20% of the difference in health spending (as a share of GDP) and 30% of the difference in health status between Europe and the U.S. We estimate a one percentage point negative impact on the life-time cost-of-living of Americans from higher prices due to inefficiencies.

Keywords: Health Production; Health Status; Heterogeneous Agent Model; Price Indices (search for similar items in EconPapers)
JEL-codes: C51 D61 E21 I10 I32 (search for similar items in EconPapers)
Date: 2020-03-30
New Economics Papers: this item is included in nep-hea and nep-mac
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://cirano.qc.ca/files/publications/2020s-16.pdf

Related works:
Working Paper: Understanding Cross-Country Differences In Health Status And Expenditures (2022)
Working Paper: Understanding Cross-country Differences in Health Status and Expenditures (2020)
Working Paper: Understanding Cross-country Differences in Health Status and Expenditures (2020)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cir:cirwor:2020s-16

Access Statistics for this paper

More papers in CIRANO Working Papers from CIRANO Contact information at EDIRC.
Bibliographic data for series maintained by Webmaster ().